Cargando…
Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695
With the rise of bacterial resistance to conventional antibiotics, re-purposing of Food and Drug Administration (FDA) approved drugs currently used to treat non-bacteria related diseases as new leads for antibacterial drug discovery has become an attractive alternative. Ethoxzolamide (EZA), an FDA-a...
Autores principales: | Rahman, Mohammad M., Tikhomirova, Alexandra, Modak, Joyanta K., Hutton, Melanie L., Supuran, Claudiu T., Roujeinikova, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158114/ https://www.ncbi.nlm.nih.gov/pubmed/32318117 http://dx.doi.org/10.1186/s13099-020-00358-5 |
Ejemplares similares
-
Anti-Helicobacter pylori activity of ethoxzolamide
por: Modak, Joyanta K., et al.
Publicado: (2019) -
Structure Based Annotation of Helicobacter pylori Strain 26695 Proteome
por: Singh, Swati, et al.
Publicado: (2014) -
Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides
por: Modakh, Joyanta K., et al.
Publicado: (2015) -
Functional Analysis of an Acid Adaptive DNA Adenine Methyltransferase from Helicobacter pylori 26695
por: Banerjee, Arun, et al.
Publicado: (2011) -
The Effects of HP0044 and HP1275 Knockout Mutations on the Structure and Function of Lipopolysaccharide in Helicobacter pylori Strain 26695
por: Liu, Ai-Ning, et al.
Publicado: (2022)